0719.HK Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 11:08):
Our systems believe the stock currently is undervalued by 0.17% compare to its pairs and should correct upwards.

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products...

Stats
Šios dienos apimtis	382 910
Vidutinė apimtis	1.26M
Rinkos kapitalizacija	8.90B
EPS	HKD0.210 ( Q1 \| 2024-03-31 )
Kita pelno data	( HKD0 ) 2024-08-21
Last Dividend	HKD0.219 ( 2023-07-07 )
Next Dividend	HKD0 ( N/A )
P/E	7.09 (Sector) 14.27 (Industry) 0
ATR14	HKD0.0110 (0.20%)

0013.HK -0.72%

0239.HK 1.24%

0455.HK 1.96%

0512.HK -0.21%

0570.HK 0.83%

0719.HK 0.75%

0858.HK 2.56%

0867.HK 0.76%

0874.HK 0.24%

0911.HK -1.75%

1011.HK -10.26%

1312.HK 3.03%

1349.HK 0.56%

1498.HK 0.00%

1513.HK 0.78%

1558.HK 5.15%

1652.HK -2.02%

1681.HK 2.58%

2161.HK 5.00%

2196.HK 0.46%

2552.HK 2.70%

2633.HK 1.56%

2877.HK -1.79%

3737.HK 0.00%

6185.HK 0.72%

6896.HK -0.65%

8049.HK -0.76%

8329.HK 3.62%

8622.HK 0.00%

9989.HK 2.52%

Koreliacija (AI algo v.1.1b): Undervalued: 0.17% HKD5.41 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.05 (neutral)

Trumpas: -0.50 (neutral)

Signal:(51.486) Neutral

Shandong Xinhua Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Shandong Xinhua Koreliacija - Valiuta/Žaliavos

0.14
( neutral )

-0.15
( neutral )

0.00
( neutral )

0.03
( neutral )

0.17
( neutral )

Shandong Xinhua Finansinės ataskaitos

Annual	2023
Pajamos:	HKD8.10B
Bruto pelnas:	HKD2.39B (29.52 %)
EPS:	HKD0.740

FY	2023
Pajamos:	HKD8.10B
Bruto pelnas:	HKD2.39B (29.52 %)
EPS:	HKD0.740

FY	2022
Pajamos:	HKD7.50B
Bruto pelnas:	HKD2.04B (27.15 %)
EPS:	HKD0.620

FY	2021
Pajamos:	HKD6.56B
Bruto pelnas:	HKD1.77B (27.04 %)
EPS:	HKD0.560

Financial Reports:

No articles found.

Shandong Xinhua Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.176 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.219 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Shandong Xinhua Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.81 - Stable (36.19%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0308	2000-05-10
Last Dividend	HKD0.219	2023-07-07
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	HKD1.419	--
Avg. Dividend % Per Year	0.00%	--
Score	3.66	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.81
Div. Directional Score	9.77	--

Next Divdend (Est)
(2024-07-29)

HKD0.240 Estimate 3.09 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.66

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
07 Jul 2023	HKD0.219	30 Nov -0001	30 Nov -0001	30 Nov -0001
15 Jul 2022	HKD0.176	30 Nov -0001	30 Nov -0001	30 Nov -0001
14 Jul 2021	HKD0.180	30 Nov -0001	30 Nov -0001	30 Nov -0001
17 Jul 2020	HKD0.131	30 Nov -0001	30 Nov -0001	30 Nov -0001
05 Jul 2019	HKD0.114	30 Nov -0001	30 Nov -0001	30 Nov -0001
06 Jul 2018	HKD0.0601	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Dec 2017	HKD0.0300	30 Nov -0001	30 Nov -0001	30 Nov -0001
04 Jul 2016	HKD0.0181	30 Nov -0001	30 Nov -0001	30 Nov -0001
30 Jun 2015	HKD0.0192	30 Nov -0001	30 Nov -0001	30 Nov -0001
06 Jun 2014	HKD0.0192	30 Nov -0001	30 Nov -0001	30 Nov -0001
30 May 2013	HKD0.00962	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Jun 2012	HKD0.0283	30 Nov -0001	30 Nov -0001	30 Nov -0001
26 May 2011	HKD0.0454	30 Nov -0001	30 Nov -0001	30 Nov -0001
24 May 2010	HKD0.0385	30 Nov -0001	30 Nov -0001	30 Nov -0001
07 May 2009	HKD0.0231	30 Nov -0001	30 Nov -0001	30 Nov -0001
23 May 2008	HKD0.0231	30 Nov -0001	30 Nov -0001	30 Nov -0001
14 May 2007	HKD0.0154	30 Nov -0001	30 Nov -0001	30 Nov -0001
08 May 2006	HKD0.0385	30 Nov -0001	30 Nov -0001	30 Nov -0001
06 May 2004	HKD0.0308	30 Nov -0001	30 Nov -0001	30 Nov -0001
07 May 2003	HKD0.0462	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3968.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
0921.HK	Ex Dividend Knight	2023-07-10	Sporadic	0.00%
2199.HK	Ex Dividend Junior	2023-09-18	Annually	0.00%
0518.HK	Ex Dividend Junior	2023-09-01	Sporadic	0.00%
1709.HK	Ex Dividend Junior	2023-09-13	Annually	0.00%
0103.HK	Ex Dividend Junior	2023-07-14	Sporadic	0.00%
8092.HK	Ex Dividend Junior	2023-08-14	Sporadic	0.00%
1171.HK	Ex Dividend Knight	2023-07-05	Annually	0.00%
2682.HK	Ex Dividend Junior	2023-09-04	Annually	0.00%
0719.HK	Ex Dividend Knight	2023-07-07	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0613	1.500	8.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0575	1.200	8.08	9.70	[0 - 0.3]
returnOnEquityTTM	0.107	1.500	9.92	10.00	[0.1 - 1]
payoutRatioTTM	0.356	-1.000	6.44	-6.44	[0 - 1]
currentRatioTTM	1.425	0.800	7.87	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.46	[0.8 - 2.5]
cashRatioTTM	0.378	1.500	9.01	10.00	[0.2 - 2]
debtRatioTTM	0.155	-1.500	7.41	-10.00	[0 - 0.6]
interestCoverageTTM	13.47	1.000	6.12	6.12	[3 - 30]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.245	2.00	9.88	10.00	[0 - 20]
debtEquityRatioTTM	0.276	-1.500	8.90	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.283	1.000	8.62	8.62	[0.2 - 0.8]
operatingProfitMarginTTM	0.0654	1.000	-0.691	-0.691	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.370	1.000	9.05	9.05	[0.2 - 2]
assetTurnoverTTM	0.937	0.800	7.09	5.67	[0.5 - 2]
Total Score				12.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	6.96	1.000	9.40	0	[1 - 100]
returnOnEquityTTM	0.107	2.50	9.95	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.245	2.00	9.92	10.00	[0 - 30]
dividendYielPercentageTTM	4.37	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.721	2.00	9.76	10.00	[0 - 30]
payoutRatioTTM	0.356	1.500	6.44	-6.44	[0 - 1]
pegRatioTTM	0.773	1.500	8.18	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0614	1.000	-0.966	0	[0.1 - 0.5]
Total Score				6.81

Shandong Xinhua Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Shandong Xinhua

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.